Repligen Corp
RGEN
Revenue
44.83M
▲3.22M▲7.74%
3 Months ChangeAssets
2.86B
▲12.66M▲0.4441%
3 Months ChangeLiabilities
875.56M
▼-3.11M▼-0.3535%
3 Months ChangeFree Cash Flow
36.36M
▲33.72M▲1274.74%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-09-18
Form 8-K
ID: 0001193125-24-221406
2024-07-30
Form 10-Q
ID: 0000950170-24-087981
2024-07-30
Form 8-K
ID: 0001193125-24-188277
2024-07-15
Form 8-K
ID: 0001193125-24-179061
2024-06-14
Form 8-K
ID: 0001193125-24-161728
2024-06-13
Form 8-K
ID: 0001193125-24-160292
2024-05-17
Form 8-K
ID: 0001193125-24-141217
2024-05-01
Form 10-Q
ID: 0000950170-24-051310
2024-05-01
Form 8-K
ID: 0001193125-24-126349
2024-03-19
Form 8-K
ID: 0001193125-24-070768